On December 11, 2024, MEDIROM Healthcare Technologies Inc. announced that two senior executives of its subsidiary, MEDIROM MOTHER Labs Inc., invested in Mother Labs’ Series A financing round. Issei Homan, Chief Technology Officer, and Yasuhiro Hayami, Chief Business Officer, participated in the funding.
The investment was made at a pre-money valuation of JPY 9 billion, which was approximately USD $59,000,000 as of December 1, 2024. This executive participation underscores a strong internal belief in the subsidiary's corporate philosophy and future growth potential.
The commitment from key leadership reinforces the validation of Mother Labs' technology and business model. This insider investment signals confidence in the strategic direction and commercialization efforts for products like the MOTHER Bracelet.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.